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A genetically encoded single-wavelength sensor for
imaging cytosolic and cell surface ATP
Mark A. Lobas1,4, Rongkun Tao1, Jun Nagai1, Mira T. Kronschläger 1,5, Philip M. Borden 2,
Jonathan S. Marvin2, Loren L. Looger 2 & Baljit S. Khakh1,3
Adenosine 5′ triphosphate (ATP) is a universal intracellular energy source and an evolutio-
narily ancient, ubiquitous extracellular signal in diverse species. Here, we report the gen-
eration and characterization of single-wavelength genetically encoded fluorescent sensors
(iATPSnFRs) for imaging extracellular and cytosolic ATP from insertion of circularly permuted
superfolder GFP into the epsilon subunit of F0F1-ATPase from Bacillus PS3. On the cell surface
and within the cytosol, iATPSnFR1.0 responds to relevant ATP concentrations (30 μM to 3
mM) with fast increases in fluorescence. iATPSnFRs can be genetically targeted to specific
cell types and sub-cellular compartments, imaged with standard light microscopes, do not
respond to other nucleotides and nucleosides, and when fused with a red fluorescent protein
function as ratiometric indicators. After careful consideration of their modest pH sensitivity,
iATPSnFRs represent promising reagents for imaging ATP in the extracellular space and
within cells during a variety of settings, and for further application-specific refinements.
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G iven widespread roles in energy homeostasis and cellsignaling1–5, several methods have been used to detectATP using small-molecule chemical approaches6, firefly
luciferase7,8, ion channel-expressing “sniffer” cells9–11, voltam-
metry12, and different types of microelectrodes13,14. Although
progress has been made, these methods, however, lack spatial
resolution, cannot be easily used in tissue slices or in vivo,
respond to off-target ligands, need sensitive photon-counting
cameras, are imprecise, and/or unavoidably damage tissue during
probe placement. Importantly, some of these methods cannot be
genetically targeted to specific cells, sub-cellular compartments or
whole organisms, and they all lack cellular-scale spatial resolu-
tion. Although luciferase is genetically encoded15, it requires the
exogenous substrate luciferin, addition of which complicates use
in tissue slices and in vivo. It also saturates at nanomolar ATP,
lower than concentrations expected during ATP signaling (~1 μM
to ~1mM) and therefore may most reliably respond as a step
function indicator. Additionally, luciferase’s bioluminescent out-
put yields low photon fluxes and limits cellular-scale resolution
imaging. Despite these potential limitations, several pioneering
studies have successfully used genetically targeted luciferase-based
probes to image ATP dynamics and this remains a useful approach
in the purinergic signaling and intracellular ATP homeostasis
fields16–19. However, to address the aforementioned limitations
more generally, genetically-encoded fluorescent ATP sensors have
been developed, including Perceval and PercevalHR20,21, ATeam22,
and QUEEN23. These sensors are valuable, but they also have some
limitations. Specifically, they either respond to ADP/ATP ratio
instead of ATP concentration or are susceptible to optical overlap
with cellular sources of auto-fluorescence, and some are incompa-
tible with single-wavelength fluorescence imaging, the workhorse of
functional fluorescence microscopy24.
In the present study, our goals were to (1) develop an ATP
sensor that could be used in routine fluorescence imaging, e.g., at
GFP’s 488 nm excitation and ~525 nm emission and (2) deploy
such a sensor on the cell surface and within cells to image ATP.
QUEEN is an excitation ratio sensor and ATeam is a fluorescence
resonance energy transfer (FRET) sensor—these methods require
customized equipment, substantially slow down imaging rates,
complicate use with other reagents, and often have a lower signal-
to-noise ratio (SNR) than single fluorescence-wavelength inten-
sity indicators. Furthermore, although FRET-based indicators can
be used in single-wavelength mode by exciting at the donor’s
excitation peak and measuring the acceptor’s sensitized emission,
such strategies fail to benefit from the ratiometric nature of FRET
and are problematic to quantify with single-wavelength ima-
ging25. Existing FRET-based ATP sensors also employ CFP/YFP
FRET, which would require excitation at 442 nm for imaging YFP
emission: 442 nm lasers are not standard on confocal microscopes
and CFP in the existing sensors has one of the lowest quantum
yields of the available GFP-based proteins. This would translate to
inefficient energy transfer from the donor’s excited state to the
acceptor by dipole–dipole coupling. In contrast, our focus to
develop a GFP-based ATP sensor is based on advances made with
the generation of GFP-based glutamate sensors, which are a
reliable workhorse in a variety of applications26,27. Furthermore,
GFP-based sensors have recently been made for a variety of small
molecules such as dopamine, acetylcholine, and GABA28–31. Our
approach of using GFP does not of course vitiate other afore-
mentioned approaches, such as the continued use of wild type or
modified luciferases16–19,32. From these perspectives, our
approach is complementary and we believe more readily inte-
grated into standard imaging regimes for cellular-scale imaging in
a variety of biological applications in cells and in vivo. As such,
we report a GFP-based genetically encoded single-wavelength
sensor for imaging cytosolic and cell surface ATP.
Results
Generation of single-wavelength ATP sensors. We considered
and initially explored a variety of potential methods to generate an
ATP sensor. After unsuccessful attempts to modify ATP-gated P2X
receptors33 and the bacterial regulatory protein GlnK1 (as in
Perceval20) to suit our needs, we turned to microbial F0F1-ATP
synthase epsilon subunits34, which have been adapted to create the
FRET sensor ATeam22 and the excitation ratio sensor
QUEEN22,23, upon which our sensors are based. The epsilon
subunit is predicted to undergo a large conformational change34
upon binding ATP (Fig. 1a), and the homologue from the ther-
mophilic bacterium Bacillus PS3 displays appropriate ATP-binding
sensitivity35. The epsilon subunit comprises eight N-terminal β-
strands followed by two C-terminal α-helices (Fig. 1a), which
extend away from the β-strands in the absence of ATP, but upon
binding cradle ATP up against the β-strands.
Circularly permuted (cpGFP)36 was inserted between the two α-
helices of the epsilon subunit after residue 107 with the expectation
that the epsilon subunit conformational change might alter
fluorescence. The first linker (L1) initially comprised Thr–Arg,
with the second linker (L2) Leu–Gly (Fig. 1a). Based on our past
experience with the glutamate sensor iGluSnFR26,27, we began
mutating residues in the linkers and ~8500 colonies were screened
to develop sensors with large ATP-dependent fluorescence intensity
increases (dF/F). The best variant from this screen had a large
change in fluorescence (maximum dF/F of ~3.9). However, it failed
to express on the surface of HEK293 cells when cloned into the
pDisplay mammalian expression vector, which uses an IgG
secretion signal and a platelet-derived growth factor receptor
(PDGFR) transmembrane domain to anchor it to the membrane.
We reasoned that a more stable form of GFP might improve folding
and trafficking, and thus cloned circularly permuted superfolder
GFP36 (cpSFGFP) in place of cpGFP. Replacing cpGFP with
cpSFGFP remedied the surface trafficking in HEK293 cells (see later
section), but greatly diminished ATP-evoked changes in fluores-
cence. To correct this, we re-optimized L1 and L2 for the cpSFGFP
construct by mutating amino acids in the linkers and slightly
changing their length; ~7000 colonies were screened (Fig. 1a, b). We
also mutated amino acids (Thr9Val and Asn78Tyr) predicted from
molecular modeling to decrease dimer formation. Through this
process, we developed two sensors that displayed large ATP-
dependent increases in fluorescence (Fig. 1a, b). In the sensor we
termed iATPSnFR1.0, the L1 linker was changed from Thr–Arg to
Val–Leu, and L2 from Leu–Gly to Gly–Leu–His. We developed a
second sensor (iATPSnFR1.1) with improved sensitivity by mutating
amino acids near the ATP-binding pocket. iATPSnFR1.1 differs
from iATPSnFR1.0 by two mutations (Ala95Lys and Ala119Ser;
Fig. 1a; Supplementary Figure 1). Both iATPSnFR1.0 and
iATPSnFR1.1 show marked improvement over QUEEN-7µ, which
does not function as a single-wavelength sensor, and over ATeam
for the same ATP concentration range (Fig. 1c). Furthermore,
inserting cpSFGFP into Queen did not result in a sensor with ATP-
evoked fluorescence increases. Purified iATPSnFR1.0 had a
maximum dF/F of ~2.4 and an EC50 of ~120 µM, whereas purified
iATPSnFR1.1 had a maximum dF/F of ~1.9 and an EC50 of ~50 µM
(Fig. 1c). Purified iATPSnFRs were not sensitive to ADP, AMP, or
adenosine at concentrations equivalent to ATP (Fig. 1d). Both
proteins displayed similar fluorescence spectra (peak excitation
490 nm, peak emission 512 nm; Fig. 1e, f). In the presence of ATP,
an increase in peak excitation and emission was observed.
Supplementary Figure 2 shows that the fluorescence peak at 400
nm, which is seen in many GFP-based sensors including QUEEN,
was essentially ATP-independent. Thus, our bacterial-based screen
yielded a genetically encoded ATP sensor with micromolar
sensitivity, large 488 nm-excited emission intensity dF/F, and little
sensitivity to ATP metabolites (Fig. 1).
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-08441-5
2 NATURE COMMUNICATIONS |          (2019) 10:711 | https://doi.org/10.1038/s41467-019-08441-5 | www.nature.com/naturecommunications
Bright
ATP
ATP
LG
111-133
cpGFP
cpGFP
cpSFGFP
cpSFGFP
cpSFGFP
cpSFGFP
Ps3 epsilon 1-106
TR QUEEN
Step 2: replace FP
AAKT
AAKT
VL
LHH
LHH
GLH
N78YT9V VL
N78Y
A95K A119S
BrightDim
ATPSpacer
PDGFR TM domain
T9V VL
GLH
GLH
Step 1: optimize linkers for 488 nm
excitation (~8500 mutants)
Step 3: optimize linkers for
488 nm excitation
(~7000 mutants)
Step 4: rational design
(~1000 mutants)
Epsilon subunit
F0F1-ATP synthase
cpSFGFP
Dima
iATPSnFR1.0
iATPSnFR1.1
b Initial cpSFGFP - Step 2
Round 1 Step 3
Step 4
Round 2
Round 3
Round 4
dF
/F
3.0
2.5
2.0
1.5
1.0
0.5
0.0
–0.5
e iATPSnFR1.1
Ex:100 µM ATP
Em:100 µM ATP
Ex: No ATP
Em: No ATP
1.0
0.8
0.6
Fl
uo
re
sc
en
ce
 (a
.u.
)
0.4
0.2
0.0
420 440 460 480 500 520
Wavelength (nm)
540 560 580 600 620
3.0
c
iATPSnFR1.0 (n = 9)
iATPSnFR1.1 (n = 10)
QUEEN (n = 4)
ATeam (n = 3)
2.5
2.0
1.5
1.0d
F/
F
0.5
0.0
–0.5
0.01 0.1 1 10 100
[ATP] µM
1000 10,000 100,000
d
2.5
2.0
1.0
1.5
(n = 3)
ATP
ADP
Adenosine
AMP
dF
/F
0.5
0.0
0.01 0.1 1 10 100
[ATP] µM
1000 10,000
f iATPSnFR1.0
Ex:100 µM ATP
Em:100 µM ATP
Ex: No ATP
Em: No ATP
1.0
0.8
0.6
Fl
uo
re
sc
en
ce
 (a
.u.
)
0.4
0.2
0.0
420 440 460 480 500 520
Wavelength (nm)
540 560 580 600 6200.01 0.1 1 10 100
[ATP] µM
1000 10,000
Im
pr
ov
e
m
e
n
t
Fig. 1 Design and optimization of a single-wavelength ATP sensor. a Schematic showing the design and workflow used to optimize QUEEN-7µ into a single-
wavelength ATP sensor with the goal of displaying the sensor on the surface of cells. b Dose–response curves of iATPSnFR over several successive rounds
of mutagenesis (Ex: 488 nm, Em: 515 nm). Fluorescence quenching at very high ATP concentrations can be observed in addition to binding-dependent
increases. c Dose–response curves for purified ATeam, QUEEN-7µ, iATPSnFR1.0, and iATPSnFR1.1. ATeam dose–response curves were acquired with Ex:
435 nm and Em: 530 nm. The other constructs were with Ex: 488 nm, Em: 515 nm. d Dose–response curves of purified iATPSnFR1.1 to ATP, ADP, AMP, and
adenosine. e, f Excitation and emission spectra for iATPSnFR1.0 and iATPSnFR1.1 in solution (the traces are the average from 48 replicates each in a 96-well
plate). The error bars represent the s.e.m. and in some cases are smaller than the symbols used for the mean. When greater than one (in the case of
exemplar traces and graphs), n is provided in the figure panels and refers to the number of independent evaluations
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Testing of ATP sensors in HEK293 cells. We initially tested the
sensors in HEK293 cells with confocal imaging. Figure 2a, b
shows three examples for cell surface targeted iATPSnFR1.0 and
iATPSnFR1.1 transiently expressed in HEK293 cells for 24 h.
Images are shown before and during ATP applications (1 mM).
The ratio of the +ATP and −ATP image is also shown on the
right for each image series (dF). From these images, it was clear
that both iATPSnFRs were expressed in HEK293 cells, targeted to
the surface of the cells and that both responded with visibly
discernible increases in fluorescence that localized to the cell
edges (Fig. 2a, b; representative of 290 and 191 cells for
iATPSnFR1.0 and iATPSnFR1.1, respectively, from four separate
transfections each). Supplementary Movies 1 and 2 for
iATPSnFR1.0 and iATPSnFR1.1 also illustrate this point. The
traces below each set of images in Fig. 1 show representative
traces for the various ATP concentrations shown and the graphs
show dose–response relations. From such experiments, we con-
cluded that both iATPSnFR1.0 and iATPSnFR1.1 functioned as
ATP sensors when extracellularly displayed on the plasma
membrane. Furthermore, in HEK293 cells co-transfected with
cytoplasmic mCherry and membrane-displayed iATPSnFR1.0 or
iATPSnFR1.1 (Fig. 3a), there was clear iATPSnFR fluorescence at
the cell edges. In contrast, fluorescence was mostly absent
from the cytoplasm, indicating proper membrane trafficking
(Fig. 3a, b).
Without optical sectioning and using wide field epifluorescence
imaging, both iATPSnFR1.0 and iATPSnFR1.1 displayed
concentration-dependent increases in fluorescence that were
rapid, maintained in ATP, and that returned to baseline upon
ATP washout (Fig. 3c). iATPSnFR1.0 displayed an EC50 of
~350 µM with a maximum dF/F of ~1.0 (Fig. 3d). Similarly,
iATPSnFR1.1 displayed an EC50 of ~140 µM with a maximum
dF/F of ~0.9 (Fig. 3e). Thus, there was a ~3-fold loss of ATP
sensitivity and decrease in peak response in both sensors when
they were extracellularly displayed compared to the soluble
proteins (similar effects are seen with other membrane-displayed
sensors26,27,31). During these experiments, we noticed that cells
expressing iATPSnFR1.1 were dimmer than those expressing
iATPSnFR1.0, and we found lower, but measurable expression
levels of iATPSnFR1.1 in relation to iATPSnFR1.0 (Fig. 3f).
However, both were expressed. Thus, iATPSnFR1.1 has a lower
ATP EC50 (more sensitive), but is not as well expressed as
iATPSnFR1.0. iATPSnFR1.1 also showed slightly more intracel-
lular accumulation than iATPSnFR1.0 (Fig. 3a).
Kinetics and ligand specificity of the ATP sensors. Using a fast
solution switcher, we assessed the response kinetics of cell-
displayed iATPSnFR1.0 and iATPSnFR1.1 in relation to iGluSnFR,
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Fig. 2 Representative images and traces for responses measured with cell surface iATPSnFRs. a The upper panels show three examples of ATP responses
for HEK293 cells expressing iATPSnFR1.0. The lower panels show representative traces and an average dose–response curve from 290 cells. b As in
(a), but for iATPSnFR1.1. The dose–response curve represents an average from 191 cells. In the dose–response curves, the error bars represent the s.e.m.
and in some cases are smaller than the symbols used for the mean. n numbers are provided in the figure panels and refer to the number of cells
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which displays fast on- and off-rates26,37. The time constants for
fluorescence increases (τon) were dose-dependent and sig-
nificantly faster for iATPSnFR1.1 than iATPSnFR1.0 (Fig. 4a, b).
In contrast, the time constants for the return to baseline (τoff) of
the ATP-dependent fluorescence increase were not different
between the two constructs, implying that the higher equilibrium
EC50 of iATPSnFR1.0 was due to slower association of ATP with
the sensor or due to slower subsequent coupling of ATP binding
to fluorescence change. In comparison, iGluSnFR was sig-
nificantly faster than both iATPSnFRs (Fig. 4a, b).
ATP is sequentially degraded to ADP, AMP, and adenosine by
ATPases and other ATP-utilizing enzymes in the cytosol and on
the cell surface. In accordance with the bacterial lysate data
(Fig. 1d), cell surface iATPSnFRs were not sensitive to ADP,
AMP, or adenosine at 1 mM (Fig. 4c). Furthermore, iATPSnFRs
were not sensitive to 1 mM GTP or 1 mM UTP (Fig. 4d), other
nucleoside triphosphates found within the cytosol and in the
extracellular space. Since the extracellular space is expected to
contain a mixture of ATP and ADP, we evaluated if 1 mM ADP
affected the response to 0.1, 0.3, and 1 mM ATP for iATPSnFR1.0
and iATPSnFR1.1. It did not (Fig. 4e). Thus, iATPSnFRs sense
ATP with negligible responses to degradative products or to
common competing nucleotides and nucleosides.
Expression of iATPSnFR1.0 in astrocytes and neurons. For
characterization in astrocytes and neurons, we focused on
iATPSnFR1.0, given its better expression. We co-expressed
iATPSnFR1.0 with mCherry in cultured U373MG astroglia and
observed good cell-surface trafficking (Fig. 5a), although there
was also an intracellular pool of the sensor. We confirmed that
iATPSnFR1.0 responded to 300 µM ATP applications with
fluorescence increases (Fig. 5b). Similar data were obtained by
expressing iATPSnFR1.0 in primary cultures of rat hippocampal
neurons (Fig. 5c). For U373MG astroglia, we determined the
iATPSnFR1.0 EC50 to be 400 µM with a maximum dF/F of 1.1
(Fig. 5d), similar to the HEK293 cell data. In hippocampal neu-
rons, iATPSnFR1.0 properly localized to membrane processes,
and application of ~1 mM ATP evoked increases in fluorescence.
In hippocampal neurons, the ATP EC50 was 630 µM and the
maximum dF/F was ~1.5 (Fig. 5e). Hence, our experiences with
iATPSnFR1.0 in solution, in HEK293 cells, in astroglia and in
hippocampal neurons demonstrate that the weakening of ATP
binding and the decrease in dF/F resulting from tethering the
sensor to the outside of the membrane bilayer is independent of
the host cell. We have observed altered sensitivity with other
sensors on the membrane26,27,31; we speculate that it results from
steric restriction from lipid head groups and membrane proteins.
We generated adeno-associated virus (AAV2/5) to express
iATPSnFR1.0 specifically in astrocytes using the GfaABC1D
promoter38. Following in vivo microinjections into the hippo-
campus, iATPSnFR1.0 co-localized with S100β-positive astrocytes,
but not NeuN-positive neurons (Supplementary Figure 3). Bath
application of ATP to multicellular preparations such as brain
slices is fraught with problems caused by the rapid hydrolysis of
ATP by cell surface ectoATPases. In order to minimize such
effects, we puffed ATP via a glass pipette with a Picospritzer.
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Fig. 3 Characterization of cell surface iATPSnFRs in HEK293 cells. a Single
planes from a confocal z-stack of transiently transfected HEK293 cells
expressing cytoplasmic mCherry and membrane-displayed iATPSnFR1.0.
b As in (a), but for iATPSnFR1.1 transiently expressed in HEK293 cells.
c Average traces for iATPSnFR1.1 (green) and iATPSnFR1.0 (red) over a
range of concentrations from 10 µM to 3mM measured with wide field
epifluorescence imaging. d, e Dose–response curves for iATPSnFR1.0 and
iATPSnFR1.1 displayed on the surface of HEK293 cells. Sensitivity (EC50),
total dynamic range (Max) and cooperativity (nH) shown. f Representative
Western blot from HEK293 cells transfected with iATPSnFR1.0 or
iATPSnFR1.1 probed for GFP (iATPSnFRs) and GAPDH (loading control).
The full-uncropped gel is shown in Supplementary Figure 9. In panel (f), the
graph shows the quantification of iATPSnFR expression from four Western
blots normalized to GAPDH loading control. The circle represents the
mean, the box the s.e.m., the whiskers the s.d., and the horizontal line the
median. The data were compared with an un-paired Students t test. In the
other panels, the error bars represent the s.e.m. and in some cases are
smaller than the symbols used for the mean. n numbers are provided in the
figure panels and refer to the number of cells for panels (c and d) and
independent evaluations for panel (f)
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-08441-5 ARTICLE
NATURE COMMUNICATIONS |          (2019) 10:711 | https://doi.org/10.1038/s41467-019-08441-5 |www.nature.com/naturecommunications 5
Puffing 3 mM ATP (for 5 s) onto U373MG astroglia resulted in a
~0.7 dF/F (Fig. 5f). Similar, albeit smaller, responses were
observed when we applied ATP to astrocytes expressing
iATPSnFR1.0 in hippocampus and spinal cord slices or to D1
or D2 medium spiny neurons expressing iATPSnFR in striatum
(Fig. 5g, h). Taken together, these data show that iATPSnFR can
be expressed and responds reliably on the surface of cells
following in vivo expression.
We next explored the use of cytosolic iATPSnFR1.0 to follow
intracellular ATP, which ranges from 1 to 3 mM in mammalian
cells39. We expressed cytosolic iATPSnFR1.0 in U373MG astroglia
and detected a significant drop in intracellular fluorescence upon
switching to 0 mM glucose (Supplementary Figure 4a), or by
applying 10 mM 2-deoxyglucose (2DOG; Supplementary Fig-
ure 4b)—an inhibitor of glycolysis40. Similarly, following in vivo
expression with AAVs, we measured a significant drop in
intracellular ATP levels as reported by the fluorescence of
iATPSnFR1.0 in hippocampal astrocytes in 0 mM glucose
(Supplementary Figure 4c; the fluorescence of co-expressed
tdTomato did not change, arguing against changes in cell shape
and volume, or other non-specific artifacts, as the cause). We
repeated these experiments for hippocampal astrocytes and CA1
pyramidal neurons, both at somata and along processes
(Supplementary Figure 4d): oxygen-glucose deprivation (OGD)
caused a substantial drop in intracellular ATP levels. We found
that fluorescence decreases of astrocytes were twice that of
neurons (Supplementary Figure 4d). Such responses were
completely reversible for astrocytes, but only partly reversible
for neurons (Supplementary Figure 4d). Furthermore, it took
longer for decreases in astrocyte ATP to begin (~10 min in OGD).
However, once ATP began to decrease in astrocytes, it took 8.0 ±
0.5 min (n= 37) to decrease by 50%, whereas in CA1 pyramidal
neuron somata and dendrites it took 13.5 ± 0.8 min (n= 26) and
17.4 ± 0.9 min (n= 27), respectively (p < 0.0001 by ANOVA and
Dunnett post hoc tests, here ± indicates plus/minus standard
error of the mean). Based on the titrations in Fig. 3, we estimate
that ATP levels fell by ~0.5 mM from >1mM. Thus during
glucose deprivation, ATP levels in astrocytes fall quickly, but
recover completely upon restoration of glucose. In contrast,
neuronal ATP levels fall slowly and fail to recover to normal
levels under the identical conditions.
mRuby-iATPSnFR1.0 as a ratiometric ATP sensor. We fused
the red fluorescent protein mRuby41 to the N-terminus of
iATPSnFR1.0 to generate a ratiometric sensor (Fig. 6a; mRuby-
iATPSnFR1.0). The mRuby-iATPSnFR1.0 construct was identical
to iATPSnFR1.0 in terms of its sensitivity and ATP-evoked dF/F
(Fig. 6b). In HEK293 cells, mRuby-iATPSnFR1.0 displayed clear
changes in green fluorescence in the presence of 2DOG, whereas
the red fluorescence of mRuby did not (Fig. 6c; Supplementary
Figure 5). Note that in Supplementary Figure 5, a field of view is
shown, but that the analyses were performed on single cells and
not by averaging across whole fields of view. Similarly, following
in vivo expression with AAVs, we measured a significant drop in
intracellular ATP as reported by the fluorescence of iATPSnFR1.0
in hippocampal astrocytes and pyramidal neuron somata and
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dendrites upon switching to solutions that mimic ischemia (i.e.,
OGD), whereas there was no change in mRuby (Fig. 6d; Sup-
plementary Figure 6). Interestingly, ATP levels returned back to
normal levels upon reapplication of physiological buffers in
astrocytes, but remained low in neuronal somata and dendrites
(Fig. 6d). We also performed two necessary control experiments.
First, we tested whether the iATPSnFR1.0 itself responded to
2DOG with a decrease in fluorescence. This was not the case
(Supplementary Figure 7). Second, we measured intracellular pH
changes in HEK293 cells during 2DOG applications. Using
confocal microscopy (Ex 473 nm, Em 525 nm), we found subtle
10% decreases in the fluorescence of the pH indicator BCECF,
which suggests acidification of the intracellular compartment by
~0.2 pH units. However, this acidification took ~45 min to reach
significance in the presence of 2DOG and was not reversible upon
reapplication of glucose (Supplementary Figure 7b). To explore
pH changes further, we also used epifluorescence dual-
wavelength ratiometric imaging with BCECF-AM (Ex 505 and
440 nm, Em 535 nm), and found the 505/440 ratio decreased
from 1.3 ± 0.03 to 1.2 ± 0.03 after 20 min of 2DOG, but did not
recover upon reapplication of glucose (1.1 ± 0.02) for 20 min
(n= 144). Hence, consistent with past work using 2DOG20 we
measured variable and subtle acidification in HEK293 cells with
2DOG applications, but these changes could not account for the
drop in mRuby-iATPSnFR1.0 fluorescence, which we associate
with a drop in ATP concentration that has been previously
reported20. For example, from calibration experiments reported
in Fig. 7c (see next section), acidification from pH 7.4 to 7.2 is
iATPSnFR1.0 mCherry Merge
20 µm 20 µm
20 µm
20 µm
20 µm20 µm
50 µm 50 µm 50 µm
Control + 300 µM ATP dF (300 µM ATP)
dF (1 mM ATP)
a
b
c
+ 1 mM ATPControl
EC50 = 403 µM
Max = 1.1 dF/F
nH = 1.21.0
0.8
0.6
0.4
0.2
0.0
(n = 63)
Astrocytesd
dF
/F
[ATP] µM
1 10 100 1000 10,000
1.0
1.2
1.4
1.6
1.8
0.8
0.6
0.4
0.2
0.0
EC50 = 630 µM
Max = 1.5 dF/F
nH = 1.6
(n = 10)
Neuronse
dF
/F
[ATP] µM
1 10 100 1000 10,000
20 µm
24 µm 24 µm 24 µm
20 µm 20 µm
Control
3 mM ATP
puff
3 mM ATP
puff
Control
ATP
ATP
dF
dF
f
g
0.1 dF/F
10 s
0.01 dF/F
10 s
(n = 50)
(n = 14)
2.0
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.2
0.0
h
Pu
ff 
ev
o
ke
d 
re
sp
on
se
 (d
F/
F)
Buffer Astroglia
Astrocytes Neurons
Brain slices
Hip SC Hip D1 MSNs D2 MSNs
(n = 7)
(n = 51)
(n = 8) (n = 8) (n = 60) (n = 51)
(n = 34)
p <
 0.
00
01
p =
 0.
00
3
p =
 0.
00
74 p <
 0.
00
01
p <
 0.
00
01
p <
 0.
00
01
Fig. 5 Characterization of cell surface and cytosolic iATPSnFR1.0 in astrocytes and neurons. a A single plane from a confocal z-stack of a U373MG cell
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the symbols used for the mean. n numbers are provided in the figure panels and refer to the number of cells
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expected to cause a 9% decrease in fluorescence of ATP-bound
mRuby-iATPSnFR1.0, whereas with 2DOG applications we
measured a change of between 40 and 50% (Fig. 6). Thus, in
accord with past studies20 such putative ATP changes were larger,
faster and reversible in HEK293 cells (Fig. 6c). We could not use
BCECF as a pH indicator for brain slice experiments because our
past work shows that membrane-permeant acetoxymethyl ester
(AM)-version organic dyes are poorly/unreliably taken up by
adult brain slices38,42. Overall, mRuby-iATPSnFR1.0 experiments
suggest that this sensor can be used as a ratiometric sensor of cell-
specific intracellular ATP levels, with the caveat that parallel
experiments to assess pH changes need to be performed on a
case-by-case basis whenever mRuby-iATPSnFR1.0 is used. We
next assessed pH sensitivity of the sensors directly.
pH sensitivity of iATPSnFR1.0 and mRuby-iATPSnFR1.0. As
with all GFP-based sensors43, the fluorescence of iATPSnFRs is
expected to be sensitive to pH with a H+ dependence largely
determined by GFP. We performed a specific set of experiments
to assess this as a guide for future use of the sensors. We focused
on iATPSnFR1.0, because this was used for most of the work
reported in this study. First, we measured the fluorescence of
extracellularly displayed iATPSnFR1.0 on the surface of HEK293
cells at a range of pH values between 4 and 9 in the absence and
presence of ATP (Fig. 7a). As expected, acidification strongly
decreased fluorescence of the ATP bound and unbound states.
Between pH 6.5 and 9, there was a strong increase in fluorescence
upon binding ATP. Second, we repeated the aforementioned
experiments with iATPSnFR1.0 in solution (from bacterial
lysates). We found the same effect with acidification for the ATP
bound and unbound states (Fig. 7b). Third, we performed similar
experiments for the mRuby-iATPSnFR1.0 sensor in solution
(from bacterial lysates) while assessing fluorescence emission in
the green ATP sensor channel and in the reference red mRuby
channel (Fig. 7c, d). For the ATP sensors, we again found that
acidification decreased fluorescence of the ATP bound and
unbound states. mRuby pH effects were not ATP-dependent,
indicating that mRuby-iATPSnFR1.0 can be used as a ratiometric
sensor (Fig. 7c, d). Fourth, we performed ATP dose–response
curves for iATPSnFR1.0 and mRuby-iATPSnFR1.0 in solution at
pH 6.4 and 7.4 (Fig. 7e, f). These data showed that acidification
decreased fluorescence responses at all concentrations of ATP
that were effective in increasing fluorescence. Overall, taken
together these data show that iATPSnFR1.0 and mRuby-
iATPSnFR1.0 function as single wavelength and ratiometric
ATP sensors, but do indeed display sensitivity to acid pH as
expected by the nature of GFP43. Perhaps more usefully, the
calibration curves shown in Fig. 7 provide a metric by which to
judge the consequences of acidification in future experiments in
which the sensors are used. The sensors are likely to be of limited
use in environments where the pH is more acidic than ~6.2.
Finally, we assessed the kinetics for ATP binding to iATPSnFR1.0
in solution at pH 7.4 and found that they did not follow typical
pseudo-first order behavior (Supplementary Figure 8), but were
instead consistent with a mechanism in which both higher and
lower fluorescent states occur (potentially resulting from mono-
meric and dimeric states). This possibility could be usefully
explored in follow up studies.
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Discussion
In the present study, we used the bright, stable cpSFGFP scaffold,
rational design, and library screening to direct the selection of
ATP sensors with desired characteristics. We characterized the
ATP sensors to monitor cell surface and cytosolic ATP levels with
excellent specificity. The current sensors may be useful to study
cytosolic ATP levels and signals associated with P2X7 receptors,
which respond to ATP in the hundreds of micromolar to milli-
molar range44, but they seem unsuitable to measure ATP release
from astrocytes which is likely in the hundreds of nanomolar to
micromolar range45. The sensors may also be useful for
diagnostics to sense high ATP levels in tumors46. Strategies for
further refinements are considered in the sections that follow.
We have tabulated the properties of iATPSnFRs in relation to
those of existing fluorescence-based ATP sensors in Supplemen-
tary Table 1. Intracellular ATP levels are typically in the milli-
molar range and change during pathology. Extracellular ATP
levels are usually low in physiological settings due to ectoAT-
Pases, but several decades of physiological studies and the exis-
tence of cell surface ATP receptors with sensitivity to ATP
between nanomolar and millimolar indicates that extracellular
ATP levels also increase during specific processes such as
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purinergic transmission5,47–52. Considering these facts, it seems
unfeasible that a single sensor will be suitable to monitor intra-
cellular and extracellular ATP levels over a concentration range
spanning 5–6 orders of magnitude. Thus, ATP sensors will need
to be designed for specific applications from those that are
available (Supplementary Table 1) and those reported herein.
It is clear that to better detect small ATP fluctuations in living
animals, the sensitivity, dF/F and kinetics of iATPSnFRs should
be improved, which could be achieved using directed evolution
strategies by employing the iATPSnFR1.0 scaffold we have
reported. Important targets for such mutagenesis include the
linker regions and the ATP-binding module itself. Furthermore, it
may be possible to use the same scaffold to design sensors for
other nucleotides and nucleosides, as with the development of
NADPH sensors for example53. Several such strategies are
underway. In these regards, progress with the generation of other
sensors such those for Ca2+, glutamate and voltage are illumi-
nating: the best available indicators were all generated after sev-
eral years and iteratively after a useful starting point scaffold and
strategy was reported. It is feasible that the development of ATP
sensors will follow a similar route based on the iATPSnFR1.0
scaffold, or others. In parallel, however, ATP G-protein coupled
receptors (GPCRs) that display a range of ATP affinities and
ligand selectivities47 could potentially be exploited to design ATP
sensors, as suggested by recent impressive strides made with the
generation of acetylcholine and dopamine sensors based on their
cognate GPCRs28–30. In evaluating these approaches, it is possible
that GPCR-based sensors have the potential to form heteromers54
with endogenous GPCRs, whereas for sensors employing engi-
neered scaffolds such as iATPSnFRs this possibility is less likely.
Finally, GFP-based ATP sensors will likely find many uses to
study the dynamics of ATP and should be considered com-
plementary to the use of luciferase-based ATP imaging approa-
ches, which have been shown to work for intra- and extracellular
ATP in cells and in vivo16–19,32. For example, it seems unlikely
that fluorescence-based ATP sensors can be used for whole-
rodent imaging, which is possible for luciferase-based sensors19.
Hence, the choice of sensor to employ will largely depend on the
specific question being addressed and careful assessment of the
contributions of pH to the signals will need to be made on a case-
by-case basis.
Overall, the iATPSnFRs reported herein and the future devel-
opments they permit (to tailor sensitivity and kinetics to specific
applications) portend the direct imaging of purinergic signaling5
throughout the body of transgenic animals. Our constructs are
available (Supplementary Table 2) to allow such studies to
commence in parallel with existing approaches discussed in ear-
lier sections.
Methods
Cloning. The QUEEN-7µ coding sequence was purchased as a gBlock Gene
Fragment from Integrated DNA Technologies with a BglII restriction site preceding
the coding sequence of QUEEN-7µ and a PstI restriction site following the coding
sequence. This gBlock was cloned into an in-house modified pRSET-A vector
(ThermoFisher: V35120), termed pHHM.pHHM contained an N-terminal His6Gly
tag utilized for purification, followed by a hemagglutinin (HA) epitope tag and a
multiple cloning site before the gene of interest, as well as a myc tag at the C-
terminus of the gene. This vector was used for screening, because it has the HA and
myc tags present in pDisplay (ThermoFisher: V66020), which is the vector we
planned to use for surface expression in mammalian cells26,55. Cloning from
pHHM to pDisplay or into pDisplayMini, an in-house vector that lacks the N-
terminal HA epitope present in pDisplay, was achieved via a restriction digest of
both the iATPSnFR and pDisplay plasmids with BglII and PstI. Cloning into the
pZAC-AAV-GfaABC1D was done using PCR amplification to add an NheI
restriction site to the N-terminus of iATPSnFR and a NotI restriction site to the C-
terminus of iATPSnFR coding sequence. Cloning was performed using routine
subcloning techniques. Note that the mRuby we used was mRuby3 minus MDE-
LYK from the C-terminus.
Protein expression and purification. Vectors containing iATPSnFR variants were
transformed into Escherichia coli BL21(DE3) cells (lacking pLysS). Proteins were
expressed by growing the E. coli in liquid auto-induction media56 supplemented
with 100 μg/ml ampicillin at 30 °C for at least 18 h. Following expression, the
bacteria were harvested at 1500g for 20 min. The pellet was resuspended in PBS
with 1M NaCl and frozen. Protein was extracted using freeze–thaw lysis and
sonication. Upon thawing, 1 µM PMSF was added to the solution before sonication.
Following sonication, the crude lysate was initially clarified at 4000g for 20 min.
The supernatant was then isolated and further clarified by centrifugation at 35,000g
for 45 min. Proteins were purified using Ni-NTA agarose affinity chromatography
(5 ml column). The iATPSnFR proteins were eluted with a 120 ml gradient from 0
to 200 mM imidazole at 2 ml/min. A blue light box was used to determine which
fractions were fluorescent. The fluorescent fractions were combined and con-
centrated down to 2–3 ml. The protein was then dialyzed with a minimum of 1 L
PBS for at least 24 h. Auto-induction media consisted of ~900 ml of ZY media (1%
tryptone and 0.5% yeast extract) with 20 ml of 50× M (25 mM Na2HPO4, 25 mM
KH2PO4, 50 mM NH4Cl and 5 mM Na2SO4), 20 ml of 50 × 5052 (0.5% glycerol,
0.05% glucose, 0.2% α-lactose), 2 ml 1M MgSO4, and 200 µl of 1000× trace metals
(50 mM FeCl3, 20 mM CaCl2, 10 mM MnCl2, 10 mM ZnSO4, 2 mM CoCl2, 2 mM
CuCl2, 2 mM NiCl2, 2 mM Na2MoO4, 2 mM Na2SeO3, 2 mM H3BO3).
Protein titrations with ATP. After protein expression, 100 µl of protein was
transferred to flat-bottom black 96-well plates (Greiner). Initial fluorescence was
assayed in a Safire2 plate-reading fluorimeter with a stacker (Tecan). Excitation/
emission wavelengths were 485/515 nm. Gain was between 80 and 120 V and
bandpass filters were 5 nm. Fluorescence was assayed again after the addition of 10
μl ATP solution containing between 315 nM and 100 mM ATP for final ATP
concentrations of 31.5 nM–10 mM. After a second reading, dF/F was calculated.
For experiments performed with clarified HEK-293 lysate, 10 cm dishes were
transfected with the cytoplasmic gene of interest. 24 h following transfection the
cells were washed twice with PBS. A third wash of PBS was used to detach the cells.
The cells were then pelleted and protein were extracted by freeze/thaw lysis. The
pH of the lysate was adjusted appropriately and the lysate was concentrated to
1.5 ml using an Amicon centrifugal filter. After the lysate was concentrated,
dose–response curves were generated as above.
For determining the pH dependence of fluorescence, buffered solutions of
specific pH were made (Hydrion Chemvelope) and concentrated, purified protein
was added to a final concentration of 0.2 µM. Fluorescence of 100 µl triplicate
samples was measured as above. ATP was added (from a 200mM stock of Mg
ATP) to a final concentration of 6 mM and fluorescence was measured again.
Stopped-flow kinetics. Equal volumes of 0.2 µM purified protein in Mg-
containing buffer (10 mM HEPES, 145 mM NaCl, 2.5 mM KCl, 10 mM Glucose, 2
mM CaCl2, 1 mM MgCl2, pH 7.4) and ATP-containing buffer (various con-
centrations) were mixed in an SX-20 stopped-flow fluorimeter (Applied Photo-
physics), with data points collected every millisecond. Excitation was from a 490
nm LED. Emission was detected with a photomultiplier tube and a 510 nm long
pass filter. Mixing reactions were performed in quintuplicate and averaged. Data
was fit to an equation containing two exponential rises:
F ¼ F0 þ ΔFmax1  1 exp kobs1  timeð Þð Þ þ ΔFmax2  1 exp kobs2  timeð Þð Þ
Mutagenesis. Linker variants and point mutations were generated by site-directed
Kunkel mutagenesis57 with a uracil template. CJ236 cells were transformed with
promising vectors and grown on plates containing chloramphenicol overnight at
37 °C. The following day a 1 ml culture of LB with only ampicillin was inoculated
with a colony and grown at 37 °C with shaking until cloudy—usually about 6 h.
Once the culture was cloudy, 1 µl of M13KO7 helper phage (NEB: N0315S) was
added. After incubating for an additional hour, the culture was expanded to a 40 ml
culture of LB with ampicillin (no chloramphenicol) in a 250 ml flask and incubated
overnight at 37 °C with shaking. The following day, the bacteria were pelleted at
4000g for 20 min at 4 °C. The supernatant was transferred to a new 50ml Falcon
tube containing 10 ml of 20% PEG in 2.5 M NaCl. After thorough mixing, the
solution was incubated on ice for 15 min. The phage was then pelleted at 4000g for
20 min. The supernatant was removed and the phage was resuspended in 2 ml of
PBS. The 2 ml of PBS were divided into two different Eppendorf tubes and cen-
trifuged at maximum speed for 5 min to pellet the remaining bacteria. The
supernatant was transferred to two new Eppendorf tubes containing 300 µl of 20%
PEG in 2.5 M NaCl. After vortexing, the solution was incubated on ice for 10 min.
The phage was pelleted at maximum speed for 5 min. The supernatant was
removed. Another quick spin was done to remove any residual supernatant. The
phage was then resuspended in 1 ml of PBS. This was centrifuged at maximum
speed for 5 min and the supernatant was transferred to a new Eppendorf tube. The
uracil template was then purified using the Qiagen QIAprep Spin M13 Kit (Cat.
No. 27704) using the manufacturer’s protocol. 11 µl of MP buffer was added to the
1 ml PBS/template solution. After vortexing, the mixture was incubated at room
temperature for 5 min. This mixture was then applied to the QIAprep spin column
and centrifuged at 4700×g. The flowthrough was discarded. After the entire mix-
ture was applied, 700 µl of PB buffer was applied to the column. After 1 min of
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incubation, the column was centrifuged at 4700×g for 15 s. This was repeated
before washing the column three times with 700 µl of PE buffer, and again cen-
trifuging at 7000 rpm for 15 s. After ensuring the column was dry, 25 µl of EB was
applied to the column which was then centrifuged at 4700×g. This was done three
times for a total of 75 µl of EB. DNA quality was checked via using agarose gel
electrophoresis. High-quality preparations run as a single band about 1/3 the size of
the plasmid.
Degenerate primers were designed to mutate two amino acids at a time. This
was done by flanking the degenerate/mutated sequence of DNA with about 15
bases of unmutated DNA on either side. A variant of QUEEN, with cpSFGFP
replacing cpEGFP was cloned by PCR. Multiple rounds of mutagenesis were
performed to screen variants with mutations at the junction of PS3 and cpSFGFP
(Linker 1) and cpSFGFP and PS3 (Linker 2). In the following primers, X indicates
the codon that was randomized to encode all possible amino acids. A Linker 2
primer encoding GHKLEYNXXDIDFKRA, resulted in a variant with the Linker
2 sequence GHKLEYNLHDIDFKRA. This was re-randomized with a number of
primers (many of which did not yield improved sensors), including a primer
encoding GHKLEYNFXLHXIDFKRA, from which the final Linker 2 sequence
GHKLEYNFGLHDIDFKRA was identified. Upon that template, Linker 1 was
optimized with a primer encoding AERRLQSQXXSHNVYIT. From a screen of a
few hundred variants, the winner (and ultimate iATPSnFR1.0) sequence
AERRLQSQVLSHNVYIT was identified. The primers were phosphorylated using
T4 kinase. The reaction was performed in an Eppendorf tube containing 18 µl H2O,
3 µl T4 Kinase buffer, 1 µl 10 µM ATP, 1 µl T4 Kinase (NEB M0201L), and 7 µl 100
µM of the oligo template. The reaction was then incubated for 30 min at 37 °C. To
determine the optimal template to primer ratio, four annealing reactions were
initially set up using four different primer dilutions of the kinased primer; 1:1, 1:5,
1:10, and 1:100. 1 µl of diluted primer, 1 µl of template and 1 µl of 10× T4 DNA
ligase buffer, and 7 µl of nuclease-free water was combined in a PCR tube. The
reaction was heated to 95 °C for 2 min using a PCR machine. The reaction was then
slowly brought back to 25 °C using 5 °C steps for 30 s each. To polymerize the
DNA, 9.5 µl water, 1.5 µl 10× T4 DNA ligase buffer, 1 µl 25 mM dNTPs, 1 µl 10
mM ATP, 1 µl T7 polymerase unmodified (NEB: M0274L), 1 µl T4 ligase (NEB:
M0202M), and the entire 10 µl annealing reaction was added to a PCR tube and
was allowed to incubate at room temperature for an hour. This reaction was
transformed directly into E. coli BL21(DE3) cells (lacking pLysS) and plated on 24
cm × 24 cm LB-Agar plates with 100 μg/ml ampicillin. After determining the
optimal concentration of kinased oligos, that dilution can be used for subsequent
reactions with that particular uracil template.
High-throughput screening. Individual colonies were selected using a QPix2xt
colony-picking robot (Genetix). Colonies were deposited into deep 96-well plates
filled with 800 µl auto-induction media with 100 μg/ml ampicillin. Cultures were
grown with vigorous shaking overnight at 30 °C. The bacteria were harvested by
centrifugation (3000g) and washed three times with 900 µl PBS before freezing.
Protein was extracted by freeze–thaw lysis with 900 µl phosphate-buffered saline.
Rapid shaking was used to homogenize the solution. Crude lysate was clarified by
centrifugation at 4000g for 30 min. 100 µl of clarified lysate was transferred to flat-
bottom black 96-well plates (Greiner) using a liquid-handling robot. Initial fluor-
escence was assayed in a Safire2 plate-reading fluorimeter with stacker (Tecan).
Excitation/emission wavelengths were 485/515 nm. Gain was between 80 and 120
V and bandpass filters were 5 nm. Fluorescence was assayed again after the addi-
tion of 10 μl 100 mM ATP (final ATP concentration 10 mM). After calculating
dF/F, new uracil templates were made for promising candidates and were subject to
subsequent rounds of mutagenesis. The most promising sensors were sequenced
and cloned into either pDisplay or pDisplayMini for further screening in mam-
malian cells.
Transfection of HEK293 and U373 cells. HEK293 (ATCC, CRL-1573) and
U373MG cells (Sigma-Aldrich, 08061901) were maintained in DMEM/F-12, sup-
plemented with GlutaMAX (Gibco: 10565042), 10% FBS (Gibco 10082147), and
5 ml penicillin–streptomycin (10,000 U/ml) (Gibco: 15140-122) at 37 °C with 5%
CO2. Cells were trypsinized once they reached confluence and were diluted at a
ratio of 1:10. HEK-293 and U373MG cells were transfected with either Lipo-
fectamine 2000 (ThermoFisher 11668027) or Effectene (Qiagen ID: 301425) fol-
lowing the manufacturer’s guidelines. The following is the procedure for the
transfection of a single well of a 6-well dish. 100 µl of OptiMEM (Gibco: 31985062)
was placed in two tubes. 2.5 µg of DNA was added to one tube and 6.25 µl of
Lipofectamine 2000 was added to the other. The content of the two tubes was
combined, thoroughly mixed, and incubated for 20 min at room temperature
before adding the mixture to cells that were 70–90% confluent with fresh media.
The media was changed 6–8 h later. 0.4 µg DNA was added to a tube, followed by 8
µl of enhancer. 100 µl of pipetted Buffer EC was used to mix the contents by
pipetting. The mixture was then incubated for 2 min before thoroughly mixing 8 µl
of Effectene into the mixture. The solution was then incubated for 10 min. 600 µl of
fresh media was added before adding the mixture to cells that were 70–90%
confluent with fresh media. The media was changed the following day.
Lysis of HEK293 cells. HEK293 cells were washed with cold PBS three times prior
to lysing cells. Cells were lysed on ice using RIPA buffer: 150 mM NaCl, 20 mM
Tris, 1 mM EDTA, 1% Triton, 0.1% SDS, and 0.5% sodium deoxycholate at pH
8 supplemented with protease inhibitors (ThermoFisher). Following the 10 min
incubation on ice, the mixture was centrifuged at max speed for 10 min. The
supernatant was taken and diluted with an equal volume of 2× Laemmli buffer for
western blot analysis.
Western blotting. Precast gels were purchased from BioRad and were run for
110 min at 100 V. 1× running buffer was composed of 3.0 g Tris base, 14.4 g glycine
and 1.0 g SDS in 1 l water. Gels were transferred to nitrocellulose for 1 h at 100 V in
1× transfer buffer. 10× transfer buffer was composed of 30.0 g Tris and 144.0 g
glycine in 1 l water. 1× Transfer buffer is composed of 10% 10× running buffer,
20% methanol, and 70% water. Following transfer, blots were blocked with 5%
bovine serum albumin (BSA) (Sigma: A9647-100G) in TBS with 0.05% Tween-20
(TBST) (Sigma: P2287-100ML) for 1 h. Antibodies were made with 5% BSA in
TBST. Primary antibodies: GAPDH 1:5000 mouse (Thermofisher MA5-15738).
GFP 1:1000 rabbit (Invitrogen A11122). Secondary antibodies: IRDye 680RD anti-
mouse 1:20,000 (Licor 926-68170). IRDye 800CW anti-rabbit 1:20,000 (Licor 925-
68024). Primary antibodies were incubated overnight at 4 °C. Following three
washes with TBST of at least 10 min each, secondary antibodies were incubated for
1 h at room temperature. Three washes with TBST of at least 10 min each were
sufficient to remove the secondary antibodies. Membranes were imaged using a
Licor Odyssey infrared imager.
AAV2/5 microinjections in vivo. All animal experiments were conducted in
accordance with the National Institute of Health Guide for the Care and Use of
Laboratory Animals and were approved by the Chancellor’s Animal Research
Committee at the University of California, Los Angeles. Wild-type C57BL/6NTac
mice were generated from in house breeding colonies or purchased from Taconic
Biosciences. All mice were housed with food and water available ad libitum in a
12 h light/dark environment. All animals were healthy with no obvious behavioral
phenotype, were not involved in previous studies, and were sacrificed during the
light cycle. Animals were initially deeply anesthetized in a chamber with 5% iso-
fluorane. The head of the animal was then shaved to remove the fur around the
surgical site. The animal had its head fixed in a stereotaxic setup using ear bars. A
nose cone was placed over the nose for continuous administration of isofluorane
throughout the procedure. There was continuous monitoring of the animal’s
breathing during the procedure and anesthesia was adjusted accordingly (0.5–3%).
The animal was administered buprenorphine (0.1 mg/kg Buprenex) and the sur-
gical site was cleaned three times with 10% povidone iodine and 70% ethanol prior
to the surgery. A small incision was made to expose the skull. A ~2 mm hole was
drilled into the skull with a high-speed drill at 2 mm posterior to bregma and
1.5 mm left of bregma for hippocampus CA1, and at 0.8 mm anterior to bregma
and 2mm left of bregma and for dorsolateral striatum. After removing a bit of the
skull, saline was applied to the surgical site to remove any debris. The CA1 region
of the hippocampus was injected with 1 µl of virus (titer 1.5E13) over the course of
5 min. The stereotaxic coordinates used are 2 mm posterior from bregma, 1.5 mm
left of the midline, and 1.6 mm from the pial surface for hippocampus CA1, and
0.8 mm anterior to bregma, 2 mm left of the midline, and 2.4 mm from the pial
surface for dorsolateral striatum. Once the injection was complete, the needle
remained in place for 10 min to allow the virus to diffuse into the tissue. The needle
was gradually removed over the course of 2 min. The surgical site was sutured.
Animals recovered in a cage placed on a heating pad. Animals were given 0.1 mg/
kg Buprenex the following day for pain. Animals were monitored after recovery to
make sure they were healthy, and they received trimethoprim sulfamethoxazole in
their food for a week following the operation. Targeting of MSNs was achieved
using a FLEX-dependent iATPSnFR1.0 AAV with D1 and D2 selective Cre mouse
lines58.
Imaging. HEK293 cells were transiently transfected with a vector encoding the IgK
leader sequence followed by iATPSnFR, GGTGGS linker, a myc tag and the
transmembrane domain of the PDGF receptor. After 24 h of incubation at 37 °C
with 5% CO2 in 6-well plates, cells were trypsinized and plated onto coverslips that
were pre-coated with poly-lysine. After another 24 h incubation at 37 °C with 5%
CO2, the coverslips were mounted to a perfusion chamber. Images were acquired
with an Olympus IXS 71 using an UplansApo 40 × 0.90 NA oil immersion lens or
an Olympus BX51WI confocal microscope with a LUMPlanFL/IR 40 × 0.80 NA
water immersion lens. Once mounted in the perfusion chamber, a constant flow of
fresh HEK293 buffer was perfused over the cells before and after the application of
ligands. ATP solutions were made up fresh daily. The steady-state fluorescence
level was calculated as an average of the images acquired in the first 30 s. Fast-
solution changes were achieved using SF-77B perfusion fast step controller from
Warner Instruments. A 3-barreled glass square (Warner cat 64-0119) was placed as
close to the cell as possible for imaging purposes. Steps of 800 µm were used to
move the barrels onto and off the cells. On and off rates were determined using
pClamp 10.6. HEK buffer: 140 mM NaCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM
HEPES, and 10 mM glucose adjusted to pH 7.4 with 5 mM NaOH. Intracellular pH
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assessments were made using BCECF-AM following the manufacturer’s instruc-
tions (Invitrogen). For confocal microscopy, we used 473 nm excitation and
525 nm emission. For epifluorescence microscopy, we used ratiometric imaging
with alternating 440 (500 ms), 505 nm (50 ms) excitation, and 535 nm emission
imaging. A monochromator (Till Photonics Polychrome IV or V) and a CCD were
used for these experiments (Till Imago from Till Photonics) with imaging being
controlled by TillVision software.
Animals were deeply anesthetized with pentobarbital (i.p.) prior to transcardial
perfusion. Once no reflexes were observed, the chest cavity was opened. The left
ventricle was impaled with a needle connected to a perfusion pump and the right
was punctured to permit transcardial perfusion. The animals were perfused with at
least 30 ml of ice-cold PBS to completely flush the blood, followed by at least 30 ml
of 10% buffered formalin to fix the tissues. Tissues were gently dissected out and
fixed overnight in 10% buffered formalin at 4 °C. Tissues were then cryoprotected
with 30% sucrose in PBS before being frozen in O.C.T. compound (Fisher
Scientific: 23-730-571). 40 µm sections were harvested using a cryostat microtome
(Leica). Sections were harvested into PBS and blocked with 10% normal goat serum
and 0.5% Triton-X 100 in PBS for 1 h at room temperature prior to staining.
Primary antibody was applied overnight at 4 °C in PBS with 10% normal goat
serum and 0.5% Triton-X 100. Sections were washed three times with PBS
following primary application. The secondary antibody was incubated at room
temperature for 1 h followed by three washes with PBS before mounting on to
slides. Sections were allowed to completely dry on the slide before applying
Fluoromount-G (SouthernBiotech: 0100-01). Primary antibodies: S100β rabbit
1:1000 (Abcam ab41548). NeuN rabbit 1:1000 (Cell Signaling D3S3I). GFP chicken
1:1000 (Abcam ab13970). Secondary antibodies: goat anti-chicken IgG Alexa 488
1:2000 (Invitrogen A11039). Goat anti-rabbit Alexa 546 1:2000 (Invitrogen
A11010). A 488 nm argon laser adjusted to 5–10% maximum output intensity was
used for imaging Alexa 488 dyes. A 543 HeNe laser adjusted to 20–30% maximum
output intensity was used for imaging Alexa 546 dyes.
A Model P-97 pipette puller from Sutter Instrument Co. was used to pull
capillaries purchased from VWR (1B100-4). Patch pipettes were filled with 3 mM
ATP and Alexa Fluor 568 hydrazide (1:200) (ThermoFisher Scientific: A10441).
Micromanipulators were used to place the tip of the pipette 10–20 μm above the
cell being imaged. A constant flow of fresh buffer perfused the imaging chamber at
all times. After 30 s of imaging, a 5 s puff of 3 mM ATP was administered via the
PicoSpritzer III from Intracel.
Animals were deeply anesthetized with isofluorane prior to decapitation. The
brain was removed as gently and as quickly as possible, and then cooled as quickly
as possible. The brain was mounted with superglue to a cutting platform and was
bathed in ice-cold hippocampal slicing buffer while 300 µm sections were harvested
using a vibratome. For spinal cord slices, a laminectomy was performed. The dura
mater and all roots were removed and the spinal cord was subsequently mounted
using superglue on an agarose block for transversal sectioning (300 µm). These
sections were then placed in 32 °C hippocampal imaging buffer. All solutions were
bubbled with 95% O2 and 5% CO2 for at least 30 min prior to slicing. Following
sectioning, the slices were placed in a perfusion chamber for imaging with a
constant flow of 2–3 ml/min of hippocampal imaging buffer. Images were taken
using an Olympus BX51WI confocal microscope with a LUMPlanFL/IR 40 × 0.80
NA water immersion lens. A 488 nm argon laser adjusted to 10–15% maximum
output intensity for imaging GFP. Hippocampal slicing buffer: 87 mM NaCl,
25 mM NaHCO3, 25 mM glucose, 2.5 mM KCl, 1.25 mM NaH2PO4, 75 mM
sucrose, 7 mM MgCl2, and 0.5 mM CaCl2. Hippocampal imaging buffer: 126 mM
NaCl, 25 mM NaHCO3, 10 mM glucose, 2.5 mM KCl, 1.24 mM NaH2PO4,
1.30 mM MgCl2, and 2.4 mM CaCl2.
Data analyses and statistics. Data from every experiment represents a minimum
of n mice (for the experiments where mice were used). In all the imaging
experiments, n was >3 independent evaluations (mice or transfections). Sample
sizes were not calculated a priori. In the figure panels and legends, n is defined as
the number of replicates (cells, dendrites, regions of interest or evaluations in the
case of biochemical evaluations) and generally refers to the numbers of cells unless
otherwise stated. For AAV injections, mice were randomly assigned to each
experimental group. No experimental data points were excluded. Statistical tests
were run in Origin 9. Summary data are presented as mean ± s.e.m. Note that in
some of the graphs, the bars representing the s.e.m. are smaller than the symbols
used to represent the mean. For each set of data to be compared, we determined
within Origin or GraphPad InStat whether the data were normally distributed or
not using the Shapiro–Wilk test. If they were normally distributed, we used
parametric tests. If the data were not normally distributed, we used non-parametric
tests. Paired and unpaired Student’s two-tailed t tests (as appropriate) and two-
tailed Mann–Whitney tests were used for most statistical analyses with significance
declared at p < 0.05. When a statistical test was employed that was not a Student’s t
test or a Mann–Whitney test for a specific case, then it is stated as such in the text.
Throughout the manuscript, the results of statistical tests (p values and n numbers)
are reported in full on the figure panels to save space in the main body of the
manuscript. Precise p values are used, but when the p value was less than 0.0001, it
is stated at p < 0.0001 because the program we used does not provide precise
numbers for such low values. n numbers are reported in the figure panels and
represent discreet samples. However, where appropriate, key statistics are also
reported in the text. Images were analyzed using ImageJ. The GECIquant pro-
gram59 plugin was used to subtract the background from images as well as to select
regions of interest. Mean gray value measurements were imported into Excel for
dF/F analysis. The final results were graphed in OriginPro 2016 and the figures
assembled in CorelDraw 2017 to generate TIFF format figure files.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All the data are available upon request from the authors. All the newly generated plas-
mids have been deposited at Addgene with accession IDs that are listed in Supplementary
Table 2.
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